Len Elikhis
Sovereign chief officer product, Len Elikhis, says the changes are a "modernisation" of its health policy to bring them into line with customers' expectations.
While there are a number of changes the key one is around its cover of cancer care. It is extending cover for chemotherapy treatments approved by Medsafe but not funded by Pharmac, and these are also being made to Sovereign's legacy products
Ongoing medical advancements are creating the need for health insurance products to evolve to ensure New Zealanders benefit from the improvements. In response to medical advancements.
The enhancements give Sovereign health customers a range of increased benefits including access to unlimited surgical cover, extended cancer care, treatment anywhere in the world, along with a range of benefits designed to support customer’s pre and post treatment.
Elikhis, says the enhancements reinforce Sovereign’s commitment to providing health cover that is truly comprehensive and meets the changing needs of the customer.
“At Sovereign we’re taking the big picture approach to supporting our customers. As medical treatments become more advanced they can require additional support services. For instance, without undergoing a dental evaluation it isn’t possible to proceed with heart valve replacement surgery. These treatments can be critical to a customer’s full recovery and long-term well-being.
Sovereign’s health cover enhancements include:
Sovereign's changes welcomed [READ ON]
« Kiwi company attracts $200 million global investment | Lifetime Group gets life business, sells general » |
Special Offers
No comments yet
Sign In to add your comment
© Copyright 1997-2025 Tarawera Publishing Ltd. All Rights Reserved